Exact Mass: 358.0202166

MPTA

C13H15N2O2. I (358.017824)

2-Iodomelatonin

C13H15IN2O2 (358.01782399999996)

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

N-Iodo-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide

C13H15IN2O2 (358.01782399999996)

Slagenin C

C12H15BrN4O4 (358.027661)

gliotoxin E|gliotoxin-E

C13H14N2O4S3 (358.01156840000004)

4-O-Demethylaustocystin A

C18H11ClO6 (358.0244136)

bis(4-nitrophenyl) phosphate hydrate

C12H11N2O9P (358.0202166)

1-(6-Chloro-9H-purin-9-yl)-1-deoxy-2,3-O-isopropylidene-beta-D-ribofuranuronoyl chloride

C13H12Cl2N4O4 (358.0235572)

tert-Butyl 3-iodo-5-methyl-1H-pyrrolo[2,3-b]pyridine-1-carboxylate

C13H15IN2O2 (358.01782399999996)

4,4-dimethoxyoctafluorobiphenyl

C14H6F8O2 (358.0240032)

4-[2,5-Bis(2,2,2-trifluoroethoxy)phenyl]-1,2,3-thiadiazole

C12H8F6N2O2S (358.02106599999996)

Mifobate

C11H17ClO7P2 (358.0138022)

C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist Mifobate (SR-202) is a potent and specific PPARγ antagonist. Mifobate (SR-202) selectively inhibits Thiazolidinedione (TZD)-induced PPARγ transcriptional activity (IC50=140 μM). Mifobate (SR-202) does not affect basal or ligand-stimulated transcriptional activity of PPARα, PPARβ, or the farnesoid X receptor (FXR). Mifobate (SR-202) shows antiobesity and antidiabetic effects[1].

3,3,4,4-Biphenyltetramine tetrahydrochloride

C12H18Cl4N4 (358.0285508)

disodium magnesium edta

C10H12MgN2Na2O8 (358.0239532)

TETRAKIS(ACETONITRILE)SILVER(I) TETRAFLUOROBORATE

C8H12AgBF4N4 (358.01420399999995)

2-Propenyl-glucosinolate

C10H16NO9S2- (358.0266466)

Allylglucosinolate

C10H16NO9S2- (358.0266466)

4-(N-Maleimido)phenyltrimethylammonium iodide

C13H15IN2O2 (358.01782399999996)

2-Iodomelatonin

C13H15IN2O2 (358.01782399999996)

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

sinigrin(1-)

C10H16NO9S2 (358.0266466)

An alkenylglucosinolate that is the conjugate base of sinigrin.

4-bromo-n-({2-hydroxy-6a-methoxy-1h,3ah,5h,6h-furo[2,3-d]imidazol-5-yl}methyl)-1h-pyrrole-2-carboxamide

C12H15BrN4O4 (358.027661)

n-{[(3as,5s,6as)-2-hydroxy-6a-methoxy-1h,3ah,5h,6h-furo[2,3-d]imidazol-5-yl]methyl}-4-bromo-1h-pyrrole-2-carboxamide

C12H15BrN4O4 (358.027661)

n-{[(3as,5r,6as)-2-hydroxy-6a-methoxy-1h,3ah,5h,6h-furo[2,3-d]imidazol-5-yl]methyl}-4-bromo-1h-pyrrole-2-carboxamide

C12H15BrN4O4 (358.027661)

n-{[(3ar,5s,6as)-2-hydroxy-3a-methoxy-3h,5h,6h,6ah-furo[2,3-d]imidazol-5-yl]methyl}-4-bromo-1h-pyrrole-2-carboxamide

C12H15BrN4O4 (358.027661)

7-hydroxy-11-(hydroxymethyl)-16-methyl-12,13,14-trithia-9,16-diazatetracyclo[9.3.2.0¹,⁹.0³,⁸]hexadeca-3,5-diene-10,15-dione

C13H14N2O4S3 (358.01156840000004)

(1r,7s,8s,11r)-7-hydroxy-11-(hydroxymethyl)-16-methyl-12,13,14-trithia-9,16-diazatetracyclo[9.3.2.0¹,⁹.0³,⁸]hexadeca-3,5-diene-10,15-dione

C13H14N2O4S3 (358.01156840000004)

n-{[(3as,5s,6ar)-2-hydroxy-3a-methoxy-3h,5h,6h,6ah-furo[2,3-d]imidazol-5-yl]methyl}-4-bromo-1h-pyrrole-2-carboxamide

C12H15BrN4O4 (358.027661)